Cargando…

Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types

The licensed human papillomavirus (HPV) vaccines elicit type-restricted immunity but do not target cutaneous HPV types of the beta genus that are associated with non-melanoma skin cancer in immune-compromised patients, and it is unclear if these diverse types share a common mechanism of infection. R...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwak, Kihyuck, Jiang, Rosie, Wang, Joshua W., Jagu, Subhashini, Kirnbauer, Reinhard, Roden, Richard B. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016295/
https://www.ncbi.nlm.nih.gov/pubmed/24816794
http://dx.doi.org/10.1371/journal.pone.0097232
_version_ 1782315486415945728
author Kwak, Kihyuck
Jiang, Rosie
Wang, Joshua W.
Jagu, Subhashini
Kirnbauer, Reinhard
Roden, Richard B. S.
author_facet Kwak, Kihyuck
Jiang, Rosie
Wang, Joshua W.
Jagu, Subhashini
Kirnbauer, Reinhard
Roden, Richard B. S.
author_sort Kwak, Kihyuck
collection PubMed
description The licensed human papillomavirus (HPV) vaccines elicit type-restricted immunity but do not target cutaneous HPV types of the beta genus that are associated with non-melanoma skin cancer in immune-compromised patients, and it is unclear if these diverse types share a common mechanism of infection. Residues 11-88 of minor capsid protein L2 contain cross-protective epitopes, and vaccination with concatamers of this region derived from as many as eight alpha HPV (L2 α11-88x8) is being developed as an alternative prophylactic vaccine with potentially broader efficacy. There is also interest in developing broadly protective topical microbicides, such as carrageenan or heparin that block HPV receptor interactions, or small molecule inhibitors of infection. Here we have examined several inhibitors of HPV infection and antisera to L2 α11-88x8 for their breadth of activity against infection by 34 HPV types from within both the alpha and beta families using pseudovirions (PsV) carrying a luciferase reporter as surrogates for native virus. We observed that both heparin and carrageenan prevented infection by mucosatropic HPV types, but surprisingly PsV of several epidermotropic alpha4 and beta HPV types exhibited increased infectivity especially at low inhibitor concentrations. Furin and γ-secretase inhibitors and L2 α11-88x8 antiserum blocked infection by all HPV PsV types tested. These findings suggest that the distinct tropism of mucosal and cutaneous HPV may reflect distinct cell surface receptor interactions, but a common uptake mechanism dependent upon furin and γ-secretase proteolytic activities. Carrageenan, which is being tested as a vaginal microbicide, broadly inhibited infection by the high-risk mucosatropic HPV PsV, but not most skin tropic alpha and beta HPV. Vaccination with an L2 multimer derived exclusively from alpha papillomavirus sequences induced antibodies that broadly neutralized PsV of all 34 HPVs from within both the alpha and beta families, suggesting each displays conserved L2 neutralizing epitopes.
format Online
Article
Text
id pubmed-4016295
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40162952014-05-14 Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types Kwak, Kihyuck Jiang, Rosie Wang, Joshua W. Jagu, Subhashini Kirnbauer, Reinhard Roden, Richard B. S. PLoS One Research Article The licensed human papillomavirus (HPV) vaccines elicit type-restricted immunity but do not target cutaneous HPV types of the beta genus that are associated with non-melanoma skin cancer in immune-compromised patients, and it is unclear if these diverse types share a common mechanism of infection. Residues 11-88 of minor capsid protein L2 contain cross-protective epitopes, and vaccination with concatamers of this region derived from as many as eight alpha HPV (L2 α11-88x8) is being developed as an alternative prophylactic vaccine with potentially broader efficacy. There is also interest in developing broadly protective topical microbicides, such as carrageenan or heparin that block HPV receptor interactions, or small molecule inhibitors of infection. Here we have examined several inhibitors of HPV infection and antisera to L2 α11-88x8 for their breadth of activity against infection by 34 HPV types from within both the alpha and beta families using pseudovirions (PsV) carrying a luciferase reporter as surrogates for native virus. We observed that both heparin and carrageenan prevented infection by mucosatropic HPV types, but surprisingly PsV of several epidermotropic alpha4 and beta HPV types exhibited increased infectivity especially at low inhibitor concentrations. Furin and γ-secretase inhibitors and L2 α11-88x8 antiserum blocked infection by all HPV PsV types tested. These findings suggest that the distinct tropism of mucosal and cutaneous HPV may reflect distinct cell surface receptor interactions, but a common uptake mechanism dependent upon furin and γ-secretase proteolytic activities. Carrageenan, which is being tested as a vaginal microbicide, broadly inhibited infection by the high-risk mucosatropic HPV PsV, but not most skin tropic alpha and beta HPV. Vaccination with an L2 multimer derived exclusively from alpha papillomavirus sequences induced antibodies that broadly neutralized PsV of all 34 HPVs from within both the alpha and beta families, suggesting each displays conserved L2 neutralizing epitopes. Public Library of Science 2014-05-09 /pmc/articles/PMC4016295/ /pubmed/24816794 http://dx.doi.org/10.1371/journal.pone.0097232 Text en © 2014 Kwak et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kwak, Kihyuck
Jiang, Rosie
Wang, Joshua W.
Jagu, Subhashini
Kirnbauer, Reinhard
Roden, Richard B. S.
Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types
title Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types
title_full Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types
title_fullStr Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types
title_full_unstemmed Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types
title_short Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types
title_sort impact of inhibitors and l2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016295/
https://www.ncbi.nlm.nih.gov/pubmed/24816794
http://dx.doi.org/10.1371/journal.pone.0097232
work_keys_str_mv AT kwakkihyuck impactofinhibitorsandl2antibodiesupontheinfectivityofdiversealphaandbetahumanpapillomavirustypes
AT jiangrosie impactofinhibitorsandl2antibodiesupontheinfectivityofdiversealphaandbetahumanpapillomavirustypes
AT wangjoshuaw impactofinhibitorsandl2antibodiesupontheinfectivityofdiversealphaandbetahumanpapillomavirustypes
AT jagusubhashini impactofinhibitorsandl2antibodiesupontheinfectivityofdiversealphaandbetahumanpapillomavirustypes
AT kirnbauerreinhard impactofinhibitorsandl2antibodiesupontheinfectivityofdiversealphaandbetahumanpapillomavirustypes
AT rodenrichardbs impactofinhibitorsandl2antibodiesupontheinfectivityofdiversealphaandbetahumanpapillomavirustypes